Conference Coverage

VIDEO: Medical apps will disrupt health care in a good way


 

AT MINIMALLY INVASIVE SURGERY WEEK

References

BOSTON – Smartphones coupled with the rapidly growing number of medical applications are the latest disruptive technologies reshaping the way physicians conduct business and interact with patients, according to Paul Alan Wetter, MD, founder and chairman of the Society of Laparoendoscopic Surgeons.

“The message really is to the physicians out there: We need to be prepared and understand as much about this as we can,” said Dr. Wetter, clinical professor emeritus at the University of Miami. “We don’t want to be, 5 years from now ... wondering what’s going, what is this change?”

In a video interview, Dr. Wetter explained how mobile devices and apps could potentially improve technology-based tools that doctors already use, such as electronic health records, by allowing patients to carry accurate and up-to-date medical information with them.

Dr. Wetter spoke at the annual Minimally Invasive Surgery Week, held by the Society of Laparoendoscopic Surgeons. He did not report any relevant financial disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

dchitnis@frontlinemedcom.com

Recommended Reading

Multifocal effort needed to rein in prescription prices
MDedge Hematology and Oncology
Many NCCN guideline authors reporting financial conflicts of interest
MDedge Hematology and Oncology
ACOs score slight bump in bonus payments
MDedge Hematology and Oncology
CMS offers lower-stress reporting options for MACRA in 2017
MDedge Hematology and Oncology
10 recommendations for the Cancer Moonshot
MDedge Hematology and Oncology
Study: One hour with patients means two hours on EHR
MDedge Hematology and Oncology
New anticancer drugs linked to increased costs, life expectancy
MDedge Hematology and Oncology
Getting prior lab results is worth the effort
MDedge Hematology and Oncology
Veterans’ keratinocyte carcinoma, actinic keratosis care cost $356 million in 2012
MDedge Hematology and Oncology
Health sector claims 4 spots among top 10 lobbyers in 2016
MDedge Hematology and Oncology